This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This guidance document, which has been issued to increase the supply of infant formula, will remain in effect until November 14, 2022, at which time the FDA will evaluate whether any extension is necessary.
In a Constituent Update released today, the FDA has made available testing results for per- and polyfluoroalkyl substances (PFAS) in seafood samples collected at retail.
When finalized, the FDA’s guidance will outline its approach to the public health importance of food allergens that are not one of the major nine food allergens identified by law in the U.S.
The FDA is conducting the consumer research on a potential symbol, which is intended to be a stylized representation of the nutrient content claim “healthy.”
The Interagency Food Safety Analytics Collaboration (IFSAC)—a collaboration between the CDC, FDA and FSIS—has published its priorities for this year and next.